While the report concedes that 80 dogs in the 178-dog pimobendan group, amounting to 45% of that group, experienced 196 "adverse events" during the trial, it fails to disclose the number of those dogs which were found to have suffered arrhythmias
There are many potential long term risks when messing with hormones, hence Im extra careful to think of the tradeoffs in patients when even considering offlabel use
Without changes in diet and exercise, weight loss progress often plateaus
Used together in appropriately selected women, HRT (started within the timing window) and a GLP-1 agonist may offer additive cardiovascular protection through complementary mechanisms: estrogen via favorable lipid effects and vascular function, GLP-1 agonists via blood pressure reduction, weight loss, and direct cardiac effects [36]
The FDA originally approved Sermorelin (under the brand name Geref) for diagnostic testing of pituitary function
Propionyl L-carnitine lends itself to the treatment of La Peyronie's disease in its broadest definition, but has proved particularly useful in patients with La Peyronie's disease at the chronic advanced stage and, surprisingly, in patients with La Peyronie's disease resistant to other "conventional" forms of therapy